Differential host immune responses after infection with wild-type or lab-attenuated rabies viruses in dogs

PLoS Neglected Tropical Diseases

Volumn 9, Issue 8, 2015, Pages

  Gnanadurai, Clement W ^a   Yang, Yang ^a,b   Huang, Ying ^a   Li, Zhenguang ^a   Leyson, Christina M ^a   Cooper, Tanya L ^a   Platt, Simon R ^a   Harvey, Stephen B ^a   Hooper, Douglas C ^c   Faber, Milosz ^c   Fu, Zhen F ^a,b  

^a UNIVERSITY OF GEORGIA   (United States)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; LIVE VACCINE; NEUTRALIZING ANTIBODY; NUCLEOPROTEIN; RABIES VIRUS ANTIBODY; TRIGAS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; RABIES VACCINE;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD ANALYSIS; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNIZATION; LD50; MEMBRANE PERMEABILITY; NONHUMAN; RABIES; RABIES VIRUS; ANIMAL; B LYMPHOCYTE; COMPARATIVE STUDY; DENDRITIC CELL; DOG DISEASES; GENETICS; IMMUNOLOGY; PHYSIOLOGY; VETERINARY; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; DOG DISEASES; DOGS; RABIES; RABIES VACCINES; RABIES VIRUS; VACCINES, ATTENUATED;

EID: 84940668553     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004023     Document Type: Article

References (61)

1. WHO. Expert Consultation on rabies. World Health Organization technical report series. 2005; 931:1-88, back cover. PubMed. PMID: 16485446
2. Dietzschold B, Schnell M, Koprowski H. Pathogenesis of rabies. Current topics in microbiology and immunology. 2005; 292:45-56. Epub 2005/06/29. PubMed. PMID: 15981467
3. Faber M, Pulmanausahakul R, Nagao K, Prosniak M, Rice AB, Koprowski H, et al. Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101(46):16328-32. PMID: 15520387
4. Lafon M. Subversive neuroinvasive strategy of rabies virus. Archives of virology Supplementum. 2004; (18):149-59. PubMed PMID: 15119770
5. Wiktor TJ, Doherty PC, Koprowski H. Suppression of cell-mediated immunity by street rabies virus. The Journal of experimental medicine. 1977; 145(6):1617-22. PMID: 301176
6. Dietzschold B, Li J, Faber M, Schnell M. Concepts in the pathogenesis of rabies. Future Virol. 2008; 3 (5):481-90. Epub 2009/07/07. doi: 10.2217/17460794.3.5.481 PMID: 19578477
7. Hemachudha T. Human rabies: clinical aspects, pathogenesis, and potential therapy. Current topics in microbiology and immunology. 1994; 187:121-43. PubMed PMID: 7859488
8. Wang ZW, Sarmento L, Wang Y, Li XQ, Dhingra V, Tseggai T, et al. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol. 2005; 79(19):12554-65. PMID: 16160183
9. Tolson ND, Charlton KM, Lawson KF, Campbell JB, Stewart RB. Studies of ERA/BHK-21 rabies vaccine in skunks and mice. Can J Vet Res. 1988; 52(1):58-62. PubMed PMID: 3280109
10. Zhang GQ, Wang HL, Mahmood F, Fu ZF. Rabies virus glycoprotein is an important determinant for the induction of innate immune responses and the pathogenic mechanisms. Vet Microbiol. 2013; 162(2-4):601-13. doi: 10.1016/j.vetmic.2012.11.031 PMID: 23265241
11. Wang H, Zhang G, Wen Y, Yang S, Xia X, Fu ZF. Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus. PloS one. 2011; 6(9):e25414. doi: 10.1371/journal.pone.0025414 PMID: 21980450
12. Faber M, Li J, Kean RB, Hooper DC, Alugupalli KR, Dietzschold B. Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(27):11300-5. doi: 10.1073/ pnas.0905640106 PMID: 19581599
13. Li J, Ertel A, Portocarrero C, Barkhouse DA, Dietzschold B, Hooper DC, et al. Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues. J Virol. 2012; 86(6):3200-10. doi: 10.1128/JVI.06699-11 PMID: 22238315
14. Yamada K, Park CH, Noguchi K, Kojima D, Kubo T, Komiya N, et al. Serial passage of a street rabies virus in mouse neuroblastoma cells resulted in attenuation: Potential role of the additional N-glycosylation of a viral glycoprotein in the reduced pathogenicity of street rabies virus. Virus Res. 2012; 165 (1):34-45. doi: 10.1016/j.virusres.2012.01.002 PMID: 22248643
15. Kissi B, Badrane H, Audry L, Lavenu A, Tordo N, Brahimi M, et al. Dynamics of rabies virus quasispecies during serial passages in heterologous hosts. The Journal of general virology. 1999; 80 (Pt 8):2041-50. PMID: 10466802
16. Alandijany T, Kammouni W, Roy Chowdhury SK, Fernyhough P, Jackson AC. Mitochondrial dysfunction in rabies virus infection of neurons. Journal of neurovirology. 2013; 19(6):537-49. doi: 10.1007/ s13365-013-0214-6 PMID: 24277436
17. Jackson AC, Kammouni W, Fernyhough P. Role of oxidative stress in rabies virus infection. Advances in virus research. 2011; 79:127-38. doi: 10.1016/B978-0-12-387040-7.00008-1 PMID: 21601046
18. Appolinario CM, Jackson AC. Antiviral therapy for human rabies. Antiviral therapy. 2014.
19. Hemachudha T, Sunsaneewitayakul B, Desudchit T, Suankratay C, Sittipunt C, Wacharapluesadee S, et al. Failure of therapeutic coma and ketamine for therapy of human rabies. Journal of neurovirology. 2006; 12(5):407-9. PMID: 17065135
20. Jackson AC. Therapy of human rabies. Advances in virus research. 2011; 79:365-75. doi: 10.1016/ B978-0-12-387040-7.00017-2 PMID: 21601055
21. Jackson AC. Current and future approaches to the therapy of human rabies. Antiviral research. 2013; 99(1):61-7. doi: 10.1016/j.antiviral.2013.01.003 PMID: 23369672
22. Centers for Disease C, Prevention. Recovery of a patient from clinical rabies-California, 2011. MMWR Morbidity and mortality weekly report. 2012; 61(4):61-5. PMID: 22298301
23. Centers for Disease C, Prevention. Recovery of a patient from clinical rabies-Wisconsin, 2004. MMWR Morbidity and mortality weekly report. 2004; 53(50):1171-3. PMID: 15614231
24. Madhusudana SN, Nagaraj D, Uday M, Ratnavalli E, Kumar MV. Partial recovery from rabies in a sixyear-old girl. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2002; 6(1):85-6.
25. Jackson AC, Reimer DL, Ludwin SK. Spontaneous recovery from the encephalomyelitis in mice caused by street rabies virus. Neuropathol Appl Neurobiol. 1989; 15(5):459-75. PMID: 2586721
26. Hamir AN, Niezgoda M, Rupprecht CE. Recovery from and clearance of rabies virus in a domestic ferret. Journal of the American Association for Laboratory Animal Science: JAALAS. 2011; 50(2):248-51. PMID: 21439220
27. Gnanadurai CW, Zhou M, He WQ, Leyson CM, Huang CT, Salyards G, et al. Presence of Virus Neutralizing Antibodies in Cerebral Spinal Fluid Correlates with Non-Lethal Rabies in Dogs. Plos Neglect Trop D. 2013; 7(9).
28. Fekadu M, Sumner JW, Shaddock JH, Sanderlin DW, Baer GM. Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein. J Virol. 1992; 66(5):2601-4. PMID: 1560518
29. Huang CT, Li ZG, Huang Y, Zhang GQ, Zhou M, Chai QQ, et al. Enhancement of blood-brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice. Antivir Res. 2014; 110:132-41. doi: 10.1016/j.antiviral.2014.07.013 PMID: 25108172
30. Kesdangsakonwut S, Sunden Y, Aoshima K, Iwaki Y, Okumura M, Sawa H, et al. Survival of rabid rabbits after intrathecal immunization. Neuropathology: official journal of the Japanese Society of Neuropathology. 2014; 34(3):277-83.
31. Zhou M, Zhou Z, Kia GS, Gnanadurai CW, Leyson CM, Umoh JU, et al. Complete genome sequence of a street rabies virus isolated from a dog in Nigeria. Genome announcements. 2013; 1(1).
32. Seif I, Coulon P, Rollin PE, Flamand A. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol. 1985; 53 (3):926-34. PMID: 2579247
33. Faber M, Faber ML, Papaneri A, Bette M, Weihe E, Dietzschold B, et al. A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J Virol. 2005; 79 (22):14141-8. PMID: 16254349
34. Zavadova J, Svrcek S, Madar M, Durove A. [Titration of rabies antibodies with the rapid fluorescence focus inhibition test]. Veterinarni medicina. 1996; 41(7):225-30. PMID: 8830448
35. Reed L. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS. Am J Epidemiol. 1938; 27(3):493-7.
36. Madhusudana SN, Malavalli BV, Thankappan UP, Sundramoorthy S, Belludi AY, Pulagumbaly SB, et al. Development and evaluation of a new immunohistochemistry-based test for the detection of rabies virus neutralizing antibodies. Hum Vaccin Immunother. 2014; 10(5):1359-65. doi: 10.4161/hv. 28042 PMID: 24583787
37. Fekadu M, Baer GM. Recovery from clinical rabies of 2 dogs inoculated with a rabies virus strain from Ethiopia. American journal of veterinary research. 1980; 41(10):1632-4. PMID: 7224288
38. Takayama N. Rabies: a preventable but incurable disease. Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy. 2008; 14(1):8-14.
39. Senior K. Rabies: a preventable killer. The Lancet Infectious diseases. 2008; 8(1):12. PMID: 18224728
40. Manual OT. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (OIE), 2012,. 2012.
41. Schutsky K, Curtis D, Bongiorno EK, Barkhouse DA, Kean RB, Dietzschold B, et al. Intramuscular inoculation of mice with the live-attenuated recombinant rabies virus TriGAS results in a transient infection of the draining lymph nodes and a robust, long-lasting protective immune response against rabies. J Virol. 2013; 87(3):1834-41. doi: 10.1128/JVI.02589-12 PMID: 23192867
42. Hemachudha T, Phanuphak P, Sriwanthana B, Manutsathit S, Phanthumchinda K, Siriprasomsup W, et al. Immunologic study of human encephalitic and paralytic rabies. Preliminary report of 16 patients. The American journal of medicine. 1988; 84(4):673-7. PMID: 2456691
43. Roy A, Hooper DC. Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity. Journal of neurovirology. 2008; 14(5):401-11. doi: 10.1080/13550280802235924 PMID: 19016377
44. Huang CT, Li Z, Huang Y, Zhang G, Zhou M, Chai Q, et al. Enhancement of blood-brain barrier permeability is required for intravenously administered virus neutralizing antibodies to clear an established rabies virus infection from the brain and prevent the development of rabies in mice. Antiviral research. 2014.
45. Kuang Y, Lackay SN, Zhao L, Fu ZF. Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection. Virus Res. 2009; 144(1-2):18-26. doi: 10.1016/j. virusres.2009.03.014 PMID: 19720239
46. Wang ZW, Sarmento L, Wang YH, Li XQ, Dhingra V, Tseggai T, et al. Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol. 2005; 79(19):12554-65. PMID: 16160183
47. Johnson N, Mansfield KL, Mckimmie CS, Fazakerley JK, Fooks AR. Host innate immune responses to rabies virus infection of the central nervous system. Immunology. 2005; 116:90-.
48. Wang HL, Zhang GQ, Wen YJ, Yang ST, Xia XZ, Fu ZF. Intracerebral Administration of Recombinant Rabies Virus Expressing GM-CSF Prevents the Development of Rabies after Infection with Street Virus. PloS one. 2011; 6(9).
49. Zhao L, Toriumi H, Wang HL, Kuang Y, Guo XF, Morimoto K, et al. Expression of MIP-1 alpha (CCL3) by a Recombinant Rabies Virus Enhances Its Immunogenicity by Inducing Innate Immunity and Recruiting Dendritic Cells and B Cells. J Virol. 2010; 84(18):9642-8. doi: 10.1128/JVI.00326-10 PMID: 20592092
50. Celis E, Wiktor TJ, Dietzschold B, Koprowski H. Amplification of rabies virus-induced stimulation of human T-cell lines and clones by antigen-specific antibodies. J Virol. 1985; 56(2):426-33. PMID: 3877176
51. Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol. 1998; 72(5):3711-9. PMID: 9557653
52. Torres-Anjel MJ, Volz D, Torres MJ, Turk M, Tshikuka JG. Failure to thrive, wasting syndrome, and immunodeficiency in rabies: a hypophyseal/hypothalamic/thymic axis effect of rabies virus. Reviews of infectious diseases. 1988; 10 Suppl 4:S710-25. PMID: 3206086
53. Perry LL, Hotchkiss JD, Lodmell DL. Murine Susceptibility to Street Rabies Virus Is Unrelated to Induction of Host Lymphoid Depletion. Journal of immunology. 1990; 144(9):3552-7.
54. Cardenas Palomo LF, de Souza Matos DC, Chaves Leal E, Bertho AL, Marcovistz R. Lymphocyte subsets and cell proliferation analysis in rabies-infected mice. Journal of clinical & laboratory immunology. 1995; 46(2):49-61.
55. Kasempimolporn S, Tirawatnapong T, Saengseesom W, Nookhai S, Sitprija V. Immunosuppression in rabies virus infection mediated by lymphocyte apoptosis. Japanese journal of infectious diseases. 2001; 54(4):144-7. PMID: 11684783
56. Vidy A, Chelbi-Alix M, Blondel D. Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J Virol. 2005; 79(22):14411-20. PMID: 16254375
57. Brzozka K, Finke S, Conzelmann KK. Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol. 2005; 79 (12):7673-81. PMID: 15919920
58. Lafon M, Megret F, Meuth SG, Simon O, Velandia Romero ML, Lafage M, et al. Detrimental contribution of the immuno-inhibitor B7-H1 to rabies virus encephalitis. Journal of immunology. 2008; 180 (11):7506-15.
59. Murphy FA. Rabies pathogenesis. Arch Virol. 1977; 54(4):279-97. PMID: 907476
60. Hooper DC, Roy A, Barkhouse DA, Li J, Kean RB. Rabies virus clearance from the central nervous system. Advances in virus research. 2011; 79:55-71. doi: 10.1016/B978-0-12-387040-7.00004-4 PMID: 21601042
61. Baer GM, Shaddock JH, Williams LW. Prolonging morbidity in rabid dogs by intrathecal injection of attenuated rabies vaccine. Infect Immun. 1975; 12(1):98-103. PMID: 1095494